SB 1198 amends Oregon law governing inhalant delivery systems, which includes vape devices and related components used to deliver nicotine or cannabinoids as vapor or aerosol. The bill keeps existing restrictions on sales to minors, retailer notice requirements, labeling rules, child-resistant packaging, and cigarette packaging requirements, while revising one specific prohibition related to how inhalant delivery systems are packaged.
Under the bill, it becomes unlawful to distribute, sell, or allow the sale of an inhalant delivery system if the product is packaged in a way that is inconsistent with rules adopted by the Oregon Health Authority. Those rules must be tailored to the specific purpose of protecting minors from the negative health effects of unlawful use. The bill also requires that any state packaging and labeling rules be consistent with applicable FDA regulations. In effect, the measure gives the Health Authority clearer authority to regulate vape packaging standards aimed at youth protection.
Impact
The bill would amend ORS 431A.175, changing the state’s tobacco and vaping product regulatory framework by replacing the prior ban on packaging deemed attractive to minors with a broader rule-based standard tied to Oregon Health Authority rules. It affects retailers, distributors, and sellers of inhalant delivery systems, and it reinforces compliance obligations for labeling, child-resistant packaging, and age-warning notices. The measure does not create a new product category, but it strengthens the state’s ability to regulate vape packaging and marketing practices through administrative rulemaking.
Sentiment
The available voting history suggests the bill had majority support in the Senate, passing committee 3-2 and then third reading 22-7. That pattern indicates generally favorable sentiment toward the bill, likely reflecting concern about youth vaping and the health risks associated with inhalant delivery systems. No committee transcript was provided, so there is no recorded floor or committee debate to show broader public testimony or detailed arguments.
Contention
The main point of contention appears to be the packaging restriction itself. The bill removes a prior prohibition on packaging that is “attractive to minors” and replaces it with a standard requiring packaging to comply with Health Authority rules that are “tailored judiciously” to protect minors. Supporters likely view this as a more defensible and precise regulatory approach, while opponents may be concerned about expanded administrative discretion or uncertainty for manufacturers and retailers. The bill also sits within the broader tension between youth protection and the regulation of lawful nicotine and cannabinoid products.